Abstract
Purpose
To evaluate the predictive ability of combining Technetium-99m-galactosyl human serum albumin (99mTc‑GSA) single-photon emission computed tomography (SPECT)/computed tomography (CT) volume and plasma clearance rate of indocyanine green (ICGK) for posthepatectomy liver failure (PHLF).
Materials and methods
Fifty patients who underwent 99mTc-GSA scintigraphy as a preoperative examination for segmentectomy or more from July 2021 to June 2023 were evaluated prospectively. Patients were divided into two groups according to the presence or absence of posthepatectomy liver failure (PHLF). Total functional liver volume (t-FLV) and remnant FLV (r-FLV) were measured from 99mTc-GSA SPECT/CT image. Future liver remnant ICGK (ICGK-F) was calculated by ICGK and remnant liver volume from CT. Area under the curve (AUC) of ICGK-F, r-FLV, r-FLV/t-FLV, ICGK × r-FLV, ICGK × r-FLV/t-FLV was calculated to evaluate predictive ability of each parameter for PHLF.
Results
PHLF was occurred in 7 patients. AUC of ICGK × r-FLV was significantly higher than that of ICGK-F (0.99; 95% confidence interval [CI]: 0.96–1 vs 0.82; 95%CI: 0.64–0.96; p = 0.036). There was no significant difference between the AUC of r-FLV, r-FLV/t-FLV, ICGK × r-FLV/t-FLV and that of ICGK-F, respectively.
Conclusion
The combination of 99mTc‑GSA SPECT/CT volume and ICGK can predict PHLF more accurately than ICGK-F.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Posthepatectomy liver failure (PHLF) is a serious complication. PHLF is associated with postoperative mortality [1]. PHLF is defined as a condition of impaired residual hepatic excretion and synthetic function due to an inadequate residual hepatic reserve after hepatectomy. Overestimation of residual liver function leads to PHLF, whereas underestimation leads to missed opportunities for patients to undergo hepatectomy, both to the detriment of patients. Therefore, accurate preoperative evaluation of future remnant liver function is important.
Indocyanine green (ICG) clearance test is one of the most reliable quantitative liver function tests. Several studies have reported that the future liver remnant plasma clearance rate of ICG (ICGK-F) is useful for predicting PHLF and mortality after major hepatectomy [2,3,4]. ICGK-F was calculated from the plasma clearance rate of ICG (ICGK) and the proportion of the remnant liver from CT volumetry. ICGK-F has been used for preoperative evaluation of hepatectomy; however, neither ICGK nor CT volumetry can be used to evaluate the heterogeneity of liver function. Therefore, this index may not precisely evaluate remnant liver function, especially when heterogeneity of liver function exists. Furthermore, the ICG clearance test mainly reflects the excretory function rather than the synthetic function of the liver. Therefore, the prediction of PHLF can be improved by combining the ICG clearance test with an additional quantitative function test that can reflect the synthetic function of the liver.
Technetium-99m-galactosyl human serum albumin (99mTc-GSA) is an asialoglycoprotein analog that specifically binds to the asialoglycoprotein receptor (ASGPR). ASGPR are expressed on the surface of hepatocytes, and the number of ASGPR decreases in patients with liver damage [5, 6]. The degree of 99mTc-GSA accumulation in the liver correlates with the degree of liver damage [7, 8], functional hepatocellular mass, and total hepatocytes number [9]. Furthermore, a small remnant liver volume has been reported as an independent predictive factor for coagulation derangement [10]. Therefore, 99mTc‑GSA scintigraphy can be used to quantitatively evaluate synthetic liver function, in addition to the ICG clearance test, for the prediction of PHLF.
In 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT), metabolic tumor volume (MTV) has been reported to be useful in predicting tumor prognosis [11,12,13,14,15,16]. MTV was measured by contouring the tumor margin, which was determined by standardized uptake value (SUV) threshold value. In addition, recent studies have reported the utility of volume based on the SUV threshold, which is similar to MTV, in single-photon emission computed tomography (SPECT)/computed tomography (CT) [17,18,19]. Volume based on SUV threshold reflects the degree of accumulation and heterogeneity of the target. Therefore, we hypothesize that the combination of ICGK as quantitative excretion liver function index and liver volume based on SUV threshold of 99mTc‑GSA SPECT/CT reflecting heterogeneity and synthetic of liver function can more accurately predict PHLF compared with ICGK-F. To the best of our knowledge, no study has evaluated the remnant liver reserve for the prediction of PHLF by combining volume based on the SUV threshold of 99mTc‑GSA SPECT/CT and the ICG clearance test.
This study aimed to evaluate the predictive ability of the combining 99mTc‑GSA SPECT/CT volume and ICGK for PHLF.
Materials and methods
Patients
This prospective study was approved by the Institutional Review Board of our institution (No. 5215). Written informed consent was obtained from all participants. Between July 2021 and June 2023, 81 consecutive patients who underwent 99mTc-GSA scintigraphy as preoperative examination for hepatectomy were enrolled in this study. The initial inclusion criteria were as follows: (1) patients who underwent segmentectomy or more and (2) patients who underwent ICG clearance test as a preoperative examination and contrast-enhanced CT as pre-and postoperative examinations. From the initial population, patients who met the following criteria were excluded from the analysis: (1) patients who did not undergo hepatectomy after preoperative examination and (2) patients who had reasons that might affect the PHLF criteria, as described below (Fig. 1).
Imaging protocols of 99mTc-GSA SPECT/CT
SPECT/CT images were obtained using an SPECT/CT scanner (Symbia T6, Siemens Healthineers, Erlangen, Germany) with a dual-head gamma camera and low-energy, high-resolution collimators. After an overnight fast, 99mTc-GSA (Nihon Medi-Physics Co., Ltd., Tokyo, Japan) at a mean dose of 266.1 MBq (range 123.4–304.9 MBq) was injected intravenously. SPECT images (step-and-shoot, 90 steps of 25 s/step, 360°, and 128 × 128 matrix) were obtained 20 min after 99mTc-GSA injection. A low-dose CT scan (helical, 130 keV, 70 mAs, and 2.5 mm slice thickness) was performed for attenuation correction. SPECT and CT images of the entire liver were obtained. The SPECT images were reconstructed using an ordered subset expectation maximization algorithm (five subsets, nine iterations) and a Gaussian filter (FWHM = 8.0 mm).
Image analysis of 99mTc-GSA SPECT/CT
The SPECT/CT images were analyzed using the free software RAVAT version 1.00 (Nihon Medi-Physics Co., Ltd., Tokyo, Japan). First, a cubic volume of interest (VOI) containing the entire liver was created. Then, the software automatically detected the region of voxel with SUV ≥ 20. The threshold was determined to match liver contours. SUV was calculated using the following formula: SUV = total radioactivity of the VOI (Bq/mL)/[injected dose (Bq)/body weight (g)]. The software automatically measured liver volume segmented above threshold (SUV ≥ 20) (Fig. 2). Liver volume was defined as the functional liver volume of total liver (t-FLV).
The resection line was determined with reference to the hepatic portal and hepatic veins on SPECT/CT images and pre-and postoperative contrast-enhanced CT images. The resection line was determined by consensus of two board-certified radiologists included in the study (Y.O., 11 years of radiology experience; S.Y., 22 years of radiology experience). Based on the resection line, the FLV of the remnant liver (r-FLV) was measured using RAVAT (Figs. 2 and 3).
Radioactivity in the syringe before and after injection, the time before and after injection, and body weight were recorded to calculate the SUV. A cross-calibration factor was calculated using a phantom to convert the SPECT count into a radioactivity value.
Imaging protocols and analysis of CT
Dynamic contrast-enhanced CT was performed using a 256-row CT scanner (Revolution CT, GE Healthcare, Chicago, IL, USA). The tube voltage was 120 kVp and the reconstruction thickness was 1.25 mm. A nonionic iodinated contrast agent (Iopamiron 370, Bayer Healthcare, Berlin, Germany) was administered intravenously. The total dose of the contrast agent was 100 ml and the injection rate was 3 ml/s. Images were obtained before injection and 34, 40, 46, 67, and 135 s after injection initiation. One patient received pre-injection and 40 and 135 s after injection initiation. Images at 67 s or 135 s after injection were used to determine resection line, because portal vein and hepatic vein were clearly enhanced. Total liver volume (t-LV) and remnant liver volume (r-LV) were measured using the AW Server software, version 3.2 (GE Healthcare, Chicago, IL, USA).
ICG clearance test
The ICG clearance test was performed as follows. A dose of 0.5 mg/kg ICG was administered intravenously, and blood was sampled before and at 5, 10, and 15 min after ICG administration. ICGK was determined using regression analysis.
ICGK-F was calculated using the following formula: ICGK × r-LV/t-LV. In addition, the ICGK × r-FLV and ICGK × r-FLV/t-FLV ratios were calculated.
Preoperative and postoperative data
Etiology of liver disease was obtained from electronic medical record. Preoperative serum levels of total bilirubin, albumin, aspartate aminotransferase, alanine aminotransferase, international normalized ratio of prothrombin time (PT-INR), and platelet counts were recorded. Postoperative serum total bilirubin and PT-INR levels were recorded daily after hepatectomy. The type of hepatectomy, the results of the pathological diagnosis, and presence or absence of cirrhosis in the background liver were recorded.
Preoperative management
If the future remnant liver volume was insufficient, portal vein embolization (PVE) or associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) was performed. PVE was performed when future remnant liver volume was less than 40% of the total liver volume on CT. ALPPS was performed when the future remnant liver volume was less than 30% of the total liver volume on CT volumetry, and the interval to hepatectomy was shortened. 99mTc-GSA scintigraphy, ICG clearance test, and contrast-enhanced CT were repeated within 1 month after PVE or ALPPS. Hepatectomy was planned again if the future remnant liver volume was > 40% of the total liver volume on the CT. Contrast-enhanced CT and SPECT/CT of post-PVE or ALPPS were used to calculate t-LV, r-LV, t-FLV, and r-FLV.
Definition of PHLF
PHLF was defined according to the criteria of the International Study Group of Liver Surgery (ISGLS) as increased PT-INR and hyperbilirubinemia on or after postoperative day 5 [20]. The cut-off values of PT-INR and serum total bilirubin level at our institute were 1.15 and 1.50 mg/dl, respectively. If the PT-INR or serum total bilirubin level increased preoperatively, PHLF was defined as increased PT-INR and hyperbilirubinemia on or after postoperative day 5 (compared with the values on the previous day). The severity of PHLF was graded based on its impact on clinical management. Grade A was defined as PHLF that did not require any changes in the clinical management of the patient. Grade B was defined as PHLF requiring noninvasive treatment. Grade C was defined as PHLF requiring an invasive treatment.
Statistical analysis
Continuous variables were expressed as medians (interquartile ranges). Continuous variables were compared between the PHLF and non-PHLF groups using the Mann–Whitney U test, and categorical variables were compared using Fisher’s exact and Chi-squared tests. Receiver-operating characteristic (ROC) curves were derived, and the area under the curve (AUC) was calculated to examine the diagnostic performance for predicting PHLF in ICGK-F, r-FLV, r-FLV/t-FLV, ICGK × r-FLV, and ICGK × r-FLV/t-FLV, respectively. The cut-off value was determined as the point closest to the upper-left corner of the ROC curve. The sensitivity and specificity of the PHLF were calculated using this cut-off value. Sensitivity and specificity for increased PT-INR or hyperbilirubinemia after hepatectomy in ICGK-F, r-FLV, and ICGK × r-FLV were calculated using the cut-off value for PHLF to examine whether synthetic reserve or excretory reserve was more influential in each index predicting PHLF. The bootstrap method with 2000 bootstrap samples was used to compare the area under the curve (AUC) values and to calculate the 95% confidence interval (CI) for sensitivity and specificity.
Statistical significance was considered when p value was less than 0.05 or 95%CI did not overlap. Statistical analysis was performed using the Bell Curve for Excel (Social Survey Research Information Co., Ltd., Tokyo, Japan) and R version 4.2.2.
Results
Of the 81 enrolled patients, 31 were excluded from the analysis. Of the 31 excluded patients, 29 were excluded, because they did not undergo hepatectomy for several reasons (e.g., detection of metastases or bilobar liver lesions on preoperative CT or MRI, and suspected benign lesions on preoperative CT or MRI). Two patients were excluded, because they received anticoagulation therapy within 5 days after hepatectomy and PHLF was not adequately evaluated by PT-INR.
Fifty patients underwent segmentectomy or more. The median (range) interval between the preoperative evaluation (99mTc-GSA scintigraphy, ICG clearance test, and contrast-enhanced CT) and hepatectomy was 20.5 (4–124) days. The types of hepatectomy included segmentectomy in 6 patients, sectionectomy in 11, hemihepatectomy in 31, and trisectionectomy in 2. In six patients, partial resection was performed in addition to the surgical procedures described above. PVE and ALPPS were performed in 5 patients (PVE in 3 patients and ALPPS in 2 patients). PHLF occurred in 7 patients (grade A in 5 patients and grade B in 2 patients). The patient characteristics according to the presence or absence of PHLF are shown in Table 1.
ICGK-F, r-FLV, r-FLV/t-FLV, ICGK × r-FLV, and ICGK × r-FLV/t-FLV were compared based on the presence or absence of PHLF (Table 2). All the parameters were significantly lower in the PHLF group than in the non-PHLF group. The AUC values, cut-off values, sensitivity, and specificity of these parameters are summarized in Table 3. The AUC of ICGK × r-FLV (0.99, 95%CI: 0.96–1.00) was significantly greater than that of ICGK-F (0.82, 95%CI: 0.64–0.96) without overlap in 95%CI. There were no significant differences among the AUC of r-FLV, r-FLV/t-FLV, ICGK × r-FLV/t-FLV, and ICGK-F. The receiver-operating characteristic (ROC) curves for each parameter are shown in Fig. 4.
The sensitivity and specificity of ICGK-F and ICGK × r-FLV for increased PT-INR and hyperbilirubinemia are summarized in Table 4. Using the cut-off values for PHLF, increased PT-INR and hyperbilirubinemia were observed in 11 and 12 patients, respectively. Specificity of ICGK × r-FLV for increased PT-INR (97.4%, 95%CI: 92.3–100%) and hyperbilirubinemia (97.4%, 95%CI: 92.1–97.4%) were significantly higher than those of ICGK-F (74.4%, 95%CI: 64.5–87.2% for increased PT-INR; 71.1%, 95%CI: 55.3–84.2% for hyperbilirubinemia) and r-FLV (79.5%, 95%CI: 66.7–92.3% for increased PT-INR; 73.7%, 95%CI: 60.5–86.8% for hyperbilirubinemia). There were no significant differences in the sensitivities of ICGK-F, r-FLV, and ICGK × r-FLV for increased PT-INR and hyperbilirubinemia.
Discussion
This study evaluated the predictive ability of the combined 99mTc‑GSA SPECT/CT volume and ICGK for PHLF compared with ICGK-F obtained from ordinary CT volumetry. In the comparison of the AUC values, ICGK × r-FLV was the only index significantly greater than ICGK-F, with a significantly higher specificity for predicting increased PT-INR and hyperbilirubinemia. This result suggests that ICGK × r-FLV is a more specific and reliable predictor for PHLF than ICGK-F.
We used volume based on SUV threshold from 99mTc‑GSA SPECT/CT images to measure remnant liver volume instead of volume measured from CT. The utility of the volume based on the SUV threshold has been reported for 18F-FDG-PET/CT and SPECT/CT [11,12,13,14,15,16,17,18,19]. Volume based on the SUV threshold reflects the degree of accumulation and heterogeneity of the target. In other words, the volume based on the SUV threshold is not just a morphological volume but also a functional volume, which is different from the volume measured using CT or MRI. Several studies have reported that MTV has higher predictability than tumor volume from MRI in tumor response to neoadjuvant chemotherapy in osteosarcoma [21, 22]. For 99mTc-GSA SPECT/CT, one study investigated the utility of liver volume based on the SUV threshold [23]. However, this study investigated whole-liver function rather than remnant liver function. Several studies also have reported utility for combination of ICG clearance test and 99mTc-GSA scintigraphy [24, 25]. However, these studies used the ratio of remnant liver volume to whole-liver volume and not the absolute remnant liver volume. The novelty of this study is the use of the absolute functional remnant liver volume based on the SUV threshold and the combination of the ICG clearance test as a quantitative whole-liver excretion function.
We considered the reasons for the high predictive ability of ICGK × r-FLV for PHLF. ICG is taken up into the liver by the same transporter as bilirubin [26, 27]. Therefore, ICG clearance test results were associated with bilirubin metabolism. In contrast, 99mTc-GSA interacts with ASGPR, which is different from the bilirubin metabolic pathway. ASGPR levels decrease in patients with cirrhosis [6]. The number of hepatocytes also decreases in cirrhosis, while their function is maintained [28]. The degree of 99mTc-GSA accumulation decreases in cirrhosis [7, 8]. Because r-FLV is the liver volume which reflects the liver accumulation of 99mTc-GSA, r-FLV is associated with the number of hepatocytes, which is considered to reflect other hepatic functions different from bilirubin metabolism, such as protein synthesis. Therefore, a combination of the ICG clearance test and 99mTc-GSA SPECT/CT can accurately evaluate the diversity of liver function.
In this study, the predictive ability of ICGK × r-FLV tended to be better than that of ICGK × r-FLV/t-FLV. If remnant liver volume is small, but its proportion of the total liver is high, r-FLV/t-FLV is calculated to be high. However, in this case, remnant liver function is not considered high, because remnant liver itself is small. Small remnant liver volume is an independent predictive factor for coagulation derangement [10]. On the other hand, r-FLV reflects remnant liver volume itself. Therefore, the ICGK × r-FLV data are considered superior to the ICGK × r-FLV/t-FLV data.
Using the same cut-off value for PHLF, the specificity of ICGK × r-FLV for increased PT-INR was significantly higher than that of ICGK-F, and r-FLV tended to be superior to ICGK in the evaluation of synthetic liver function. Similarly, using the same cut-off value for PHLF, the specificity of ICGK × r-FLV for hyperbilirubinemia was significantly higher than that of ICGK-F, and ICGK tended to be superior to r-FLV in the evaluation of liver function excretion. T-bilirubin reflects bilirubin metabolism and PT-INR reflects protein synthesis ability. Therefore, this result indicates that ICGK × r-FLV reflects both bilirubin metabolism and protein synthesis more accurately than ICGK-F. This result supported our hypothesis.
This study suggests that ICGK × r-FLV levels can predict PHLF with high sensitivity and specificity. We consider high specificity particularly important, because it implies low false positives. If ICGK × r-FLV was above the cut-off value, PHFL was considered unlikely. This indicates that ICGK × r-FLV can be used as a reliable indicator of safe hepatectomy.
This study has several limitations. First, this was a single-center study, and the number of patients was relatively small. Further multicenter studies with larger sample sizes are required to validate the results of this study. Second, most PHLF cases were classified as grade A, which was defined as PHLF that did not require clinical treatment. Therefore, this may lead to an overdiagnosis of PHLF. Third, not all the participants underwent hepatectomy. Therefore, the effects of selection bias cannot be excluded. Fourth, patient cohort was heterogeneous. There was no significant difference in the frequency of liver cirrhosis and etiology of liver disease between the PHLF and no PHLF group. However, the small number of patients in each category did not allow for subgroup analysis in each category. Further studies with larger sample sizes are required.
In conclusion, ICGK × r-FLV obtained from 99mTc‑GSA SPECT/CT and ICG clearance test can be a reliable predictor for PHLF compared to ICGK-F obtained from ordinary CT volumetry.
Availability of data and materials
All imaging and assessment results were stored as electronic data. These data are available to the public upon request.
Code availability
Not applicable.
References
Reissfelder C, Rahbari NN, Koch M, Kofler B, Sutedja N, Elbers H, et al. Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg. 2011;98:836–44.
Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.
Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260–8.
Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Yamaguchi J, et al. The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg. 2016;40:1440–7.
Baenziger JU, Maynard Y. Human hepatic lectin. Physiochemical properties and specificity. J Biol Chem. 1980;255:4607–13.
Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Gastroenterology. 1984;87:1217–21.
Ha-Kawa SK, Tanaka Y, Hasebe S, Kuniyasu Y, Koizumi K, Ishii Y, et al. Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med. 1997;24:130–7.
Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, et al. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med. 1999;40:1652–6.
Miki K, Kubota K, Inoue Y, Vera DR, Makuuchi M. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. J Nucl Med. 2001;42:733–7.
Kim YK, Shin WJ, Song JG, Jun IG, Kim HY, Seong SH, et al. Factors associated with changes in coagulation profiles after living donor hepatectomy. Transplant Proc. 2010;42:2430–5.
Hyun SH, Ahn HK, Kim H, Ahn MJ, Park K, Ahn YC, et al. Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2014;41:50–8.
Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, et al. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer. J Nucl Med. 2014;55:898–904.
Tamaki N, Hirata K, Kotani T, Nakai Y, Matsushima S, Yamada K. Four-dimensional quantitative analysis using FDG-PET in clinical oncology. Jpn J Radiol. 2023;41:831–42.
Iwasa H, Nagamachi S, Nakayama S, Yamamoto T, Yoshimitsu K. The reproducibility of MTV and TLG of soft tissue tumors calculated by FDG-PET: comparison between the lower limit by the fixed value SUV 2.5 and that value by 30% of SUVmax. Jpn J Radiol. 2023;41:531–40.
Yuan H, Tan X, Sun X, He L, Li D, Jiang L. Role of 18F-FDG PET/CT and sarcopenia in untreated non-small cell lung cancer with advanced stage. Jpn J Radiol. 2023;41:521–30.
Ni M, Wang S, Liu X, Shi Q, Zhu X, Zhang Y, et al. Predictive value of intratumor metabolic and heterogeneity parameters on [18F]FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma. Jpn J Radiol. 2023;41:209–18.
Umeda T, Koizumi M, Fukai S, Miyaji N, Motegi K, Nakazawa S, et al. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Ann Nucl Med. 2018;32:105–13.
Ichikawa H, Shibutani T, Onoguchi M, Taniguchi Y. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT. Ann Nucl Med. 2022;36:941–50.
Matsuda N, Otsuka H, Otani T, Azane S, Kunikane Y, Otomi Y, et al. New quantitative indices of cardiac amyloidosis with 99mTc-pyrophosphate scintigraphy. Jpn J Radiol. 2023;41:428–36.
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24.
Im HJ, Kim TS, Park SY, Min HS, Kim JH, Kang HG, et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012;39:39–49.
Byun BH, Kong CB, Lim I, Kim BI, Choi CW, Song WS, et al. Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18F-FDG PET/CT and MRI. Eur J Nucl Med Mol Imaging. 2014;41:1553–62.
Nakajo M, Jinguji M, Tani A, Hirahara D, Nagano H, Takumi K, et al. Application of a machine learning approach to characterization of liver function using 99mTc-GSA SPECT/CT. Abdom Radiol. 2021;46:3184–92.
Sumiyoshi T, Okabayashi T, Negoro Y, Hata Y, Noda Y, Sui K, et al. 99mTc-GSA SPECT/CT fusion imaging for hepatectomy candidates with extremely deteriorated ICG value. Jpn J Radiol. 2018;36:537–43.
Iwaki K, Kaihara S, Kita R, Kitamura K, Hashida H, Uryuhara K. Indocyanine green plasma clearance rate and 99mTc-galactosyl human serum albumin single-photon emission computed tomography evaluated preoperative remnant liver. World J Clin Cases. 2022;10:8844–53.
de Graaf W, Hausler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, et al. Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine green. J Hepatol. 2011;54:738–45.
Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276:9626–30.
Kawasaki S, Imamura H, Bandai Y, Sanjo K, Idezuki Y. Direct evidence for the intact hepatocyte theory in patients with liver cirrhosis. Gastroenterology. 1992;102:1351–5.
Acknowledgements
The authors would like to thank Honyaku Center Inc. for English language editing.
Funding
This study did not receive any funding.
Author information
Authors and Affiliations
Contributions
Yukinori Okajima and Akira Yamada contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Yukinori Okajima, Shin Yanagisawa, and Akira Yamada. The first draft of the manuscript was written by Yukinori Okajima and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest relevant to the content of this article.
Ethics approval
Institutional Review Board approval from the Ethics Committee of Shinshu University (No. 5215) was obtained.
Informed consent
Written informed consent was obtained from all individual participants included in the study.
Consent for publication
The participants consented to the submission of this manuscript to the journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Okajima, Y., Yanagisawa, S., Yamada, A. et al. Predictability of combining Technetium-99m-galactosyl human serum albumin single-photon emission computed tomography/computed tomography and indocyanine green clearance test for posthepatectomy liver failure. Jpn J Radiol (2024). https://doi.org/10.1007/s11604-024-01613-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11604-024-01613-4